CC-292
Showing 1 - 25 of 1,010
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Healthy Volunteers Trial in Evansville (CC-292, Oral Omeprazole (OMP))
Completed
- Healthy Volunteers
- CC-292
- Oral Omeprazole (OMP)
-
Evansville, IndianaCovance Clinical Research unit
Aug 11, 2020
Palmoplantaris Pustulosis Trial in Japan (Apremilast, Placebo)
Completed
- Palmoplantaris Pustulosis
- Apremilast
- Placebo
-
Ichinomiya, Aichi, Japan
- +21 more
Dec 9, 2021
Leukemia Lymphocytic Chronic B-Cell Trial in Austria, United States (CC-292, Lenalidomide)
Completed
- Leukemia Lymphocytic Chronic B-Cell
- CC-292
- Lenalidomide
-
Huntsville, Alabama
- +10 more
Dec 19, 2019
Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,
Recruiting
- Locally Advanced (Inoperable) or Metastatic Breast Cancer
- Capivasertib
- +3 more
-
Los Angeles, California
- +76 more
Nov 25, 2022
Acromioclavicular Joint Dislocation Trial in Chon Buri (K-wire)
Recruiting
- Acromioclavicular Joint Dislocation
- K-wire
-
Chon Buri, ThailandQueen Savang Vadhana Memorial Hospital
May 2, 2023
Malaria Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Pvs230D1-EPA/Matrix-M)
Not yet recruiting
- Malaria
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 28, 2023
Cervical Cancer Trial (Game Changers for Cervical Cancer Prevention)
Not yet recruiting
- Cervical Cancer
- Game Changers for Cervical Cancer Prevention
- (no location specified)
Aug 17, 2023
Sample Collection From Healthy Volunteers for Assay Optimization
Recruiting
- Healthy Volunteers
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 1, 2022
Host-Microbiome Interactions in Health and Disease
Recruiting
- Healthy Controls
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Colorectal Cancer Trial (Administration of CC-3)
Not yet recruiting
- Colorectal Cancer
- Administration of CC-3
- (no location specified)
Aug 11, 2023
Healthy Adults Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Bismuth subsalicylate)
Not yet recruiting
- Healthy Adults
- Bismuth subsalicylate
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 11, 2023
Advanced Solid Tumors Trial in Madrid ([14C]CC-90010, CC-90010)
Not yet recruiting
- Advanced Solid Tumors
-
Madrid, M, Spain
- +1 more
Dec 23, 2022
Autoinflammatory Diseases
Recruiting
- NOMID
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
Risk Behaviors in Adolescents With Chronic Diseases
Recruiting
- Chronic Disease
- Somatic Disorders
- Questionnaire risk behaviors in adolescents with chronic diseases
-
Paris, FranceRobert Debre Hospital
Mar 20, 2023
Prostate Cancer Recurrent Trial in Tuebingen (CC-1 Infusion)
Recruiting
- Prostate Cancer Recurrent
- CC-1 Infusion
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Jan 10, 2023
Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)
Not yet recruiting
- Follicular Lymphoma
- Tumor
-
Houston, TexasM D Anderson Cancer Center
Oct 30, 2023
Relapsed/Refractory B-cell Lymphoma Trial in France (CC-292 + lenalidomide)
Completed
- Relapsed/Refractory B-cell Lymphoma
- CC-292 + lenalidomide
-
Créteil, France
- +5 more
Mar 6, 2018